The autoimmune treatment market size is expected to see rapid growth in the next few years. It will grow to $12.64 billion in 2028 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to precision medicine approaches, emergence of small molecule therapies, targeting novel pathways, gene therapy innovations, increasing biopharmaceutical investments, biosimilar market growth. Major trends in the forecast period include advancements in biologics and targeted therapies, immunomodulatory therapies, focus on rare autoimmune diseases, telemedicine and remote monitoring, regulatory initiatives and drug approvals, integration of digital health tools.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Scope Of Autoimmune Treatment Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Autoimmune Treatment Market Overview
Market Drivers –
The increase in investments in research and development of drugs for autoimmune diseases are expected to propel the growth of the autoimmune treatment market going forward. Research and development are the actions businesses take to innovate and launch new goods and services. Research and development of drugs for autoimmune diseases allows for the development of more targeted, low-molecular-weight, orally active, and chemically characterized immune suppressive drugs with acceptable tolerability in the context of long-term autoimmune disease treatment. For instance, in January 2022, Eli Lilly and Company, a US-based pharmaceutical company, increased its R&D investment from $7 billion in 2021 to $7.19 billion in 2022, resulting in an increase in its R&D spend as a percentage of revenue from 24.8% to 25.19%. Therefore, the increasing investments in research and development of drugs drives the autoimmune treatment market growth.
Market Trends –
Technological advancements are a key trend gaining popularity in the autoimmune treatment market. Major companies operating in the market are developing advanced technologies to sustain their position in the market. For instance, in June 2023, UCB, a Belgium-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for RYSTIGGO (rozanolixizumab-noli) in the treatment of generalized myasthenia gravis (gMG) in adults who test positive for anti-acetylcholine receptor (AchR) or anti-muscle-specific tyrosine kinase (MuSK) antibodies, with the approval being expedited under Priority Review. RYSTIGGO stands as the exclusive FDA-approved therapy for both anti-AchR and anti-MuSK antibody-positive gMG, encompassing the two most prevalent subtypes of this condition diagnosis of autoimmune illnesses, which might improve provider efficiency, increase the efficacy of treatment, and improve patient care.
The autoimmune treatment market covered in this report is segmented –
1) By Product: Consumables and Assay Kits, Instruments, Services
2) By Service Type: Consultation and Diagnosis, Therapy and monitoring, Drug development
3) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases
4) By Drug Class: Anti-Inflammatory, Anti-Hyperglycemics, NSAIDs, Interferons, Other Drug Class
5) By End User: Clinical Laboratories, Hospitals, Other End Users
Get an inside scoop of the autoimmune treatment market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp
Regional Insights –
North America was the largest region in the autoimmune treatment market in 2023. The regions covered in the autoimmune treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the autoimmune treatment market report are Abbott Laboratories, Amgen Inc., Johnson & Johnson Services Inc., Eli Lilly and Company, Pfizer Inc., Hoffmann-La Roche AG, AstraZeneca plc, Bristol-Myers Squibb Company, Autoimmune Inc., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Biogen Idec Inc., Bayer Schering Pharma AG, GSK plc, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., Amarin Corporation plc, AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Biohaven Pharmaceutical Holding Company Ltd., BioMarin Pharmaceutical Inc., bluebird bio Inc., Cabaletta Bio Inc., Catabasis Pharmaceuticals Inc., Celsion Corporation, ChemoCentryx Inc., Coherus BioSciences Inc., Corbus Pharmaceuticals Holdings Inc., CRISPR Therapeutics AG, CSL Limited, Cumberland Pharmaceuticals Inc., CytoDyn Inc.
Table of Contents
1. Executive Summary
2. Autoimmune Treatment Market Report Structure
3. Autoimmune Treatment Market Trends And Strategies
4. Autoimmune Treatment Market – Macro Economic Scenario
5. Autoimmune Treatment Market Size And Growth
…..
27. Autoimmune Treatment Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Read Related Topics:
https://goodprnews.com/subscription-billing-management-market-size/
https://goodprnews.com/transmission-fluids-market-size/
https://goodprnews.com/veterinary-pain-management-market-size/
https://topprnews.com/subscription-billing-management-market-share/
https://topprnews.com/transmission-fluids-market-share/
https://topprnews.com/veterinary-pain-management-market-share/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
